GlassScriptPhysician profile
Joseph S Cerni
NPI 1982874954
$33,263.89
in general payments reported to CMS, 2019-2025
6 companies · $2,511 in 2025
The $2,511 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,976 · 2020: $621 · 2021: $9,456 · 2022: $2,921 · 2023: $6,381 · 2024: $4,398 · 2025: $2,511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,146 · Food and Beverage: $4,135 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,146.25 |
| Food and Beverage | $4,135.27 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $17,022.56 | 2019-2023 | |
| Abbvie INC. | $10,941.90 | 2023-2025 | Botox |
| Apyx Medical Corporation | $1,495.77 | 2019 | |
| Merz North America, INC. | $1,483.74 | 2019-2024 | Xeomin |
| Galderma Laboratories, L.P. | $1,331.64 | 2019-2024 | |
| Revance Therapeutics, INC. | $988.28 | 2024-2025 | Daxxify, Daxi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Cerni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.